Low-dose aspirin and risk of cataract and subtypes in a randomized trial of U.S. physicians

Ophthalmic Epidemiology

Volumn 5, Issue 3, 1998, Pages 133-142

  Christen, William G ^a,e   Manson, Joann E ^a,c   Glynn, Robert J ^a,c   Ajani, Umed A ^a   Schaumberg, Debra A ^a   Sperduto, Robert D ^d   Buring, Julie E ^a,b,c   Hennekens, Charles H ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d NATIONAL EYE INSTITUTE   (United States)

^e NONE   (United States)

Author keywords

Aspirin; Cataract subtypes; Physicians' Health Study; Randomized clinical trial

Indexed keywords

ACETYLSALICYLIC ACID; BETA CAROTENE;

ADULT; AGE; AGED; ARTICLE; CATARACT; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; MORBIDITY; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCLEROSIS; SELF REPORT; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CATARACT; CATARACT EXTRACTION; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PHYSICIANS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 0031715438     PISSN: 09286586     EISSN: None     Source Type: Journal    
DOI: 10.1076/opep.5.3.133.8368     Document Type: Article

References (27)

1. National Advisory Eye Council. Vision Research, a National Plan, 1994-1998. NIH Publication No. 93-3186, Bethesda, MD: National Institutes of Health, 1993.
2. Steinberg EP, Javitt JC, Sharkey PD, et al. The content and cost of cataract surgery. Arch Ophthalmol 1993;111:1041-9.
3. Rao GN, Lardis MP, Cotlier E. Acetylation of lens crystalline: a possible mechanism by which aspirin could prevent cataract formation. Biochem Biophys Res Commun 1985;128:1125-32.
4. Harding JJ, Van Heyningen RV. Drugs, including alcohol, that act as risk factors for cataract, and possible protection against cataract by aspirin-like analgesics and cyclopenthiazide. Br J Ophthalmol 1988;72:809-14.
5. Cotlier E, Sharma YR. Aspirin and senile cataracts in rheumatoid arthritis. Lancet 1981;1:338-9.
6. Mohan M, Sperduto RD, Angra SK, et al. India-US case-control study of age-related cataracts. Arch Ophthalmol 1989:107:670-6.
7. Chen TT, Hockwin O, Dobbs R, Knowles W, Echerskorn U. Cataract and health status: a case-control study. Ophthalm Res 1988;20:1-9.
8. Seigel D, Sperduto RD, Ferris F. Aspirin and cataracts. Ophthalmology 1982;89:47A-9A.
9. West SK, Munoz BE, Newland HS, Emmett EA, Taylor HR. Lack of evidence for aspirin use and prevention of cataracts. Arch Ophthalmol 1987;105:1229-31.
10. Klein BK, Klein R, Moss S. Is aspirin use associated with lower rates of cataracts in diabetic individuals? Diabetes Care 1987;10:495-9.
11. UK-TIA Study Group. Does aspirin affect the rate of cataract formation? Cross-sectional results during a randomized double-blind placebo controlled trial to prevent serious vascular events. Br J Ophthalmol 1992;70:259-61.
12. The Italian-American Study Group. Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. Am J Epidemiol 1991;133:541-53.
13. Leske MC, Chylack LT, Wu S-Y. The lens opacities case-control study: risk factors for cataract. Arch Ophthalmol 1991;109:244-51.
14. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Aspirin use and chronic diseases: a cohort study of the elderly. Br Med J 1989;299: 1247-50.
15. Hankinson SE, Seddon JM, Colditz GA, et al. A prospective study of aspirin use and cataract extraction in women. Arch Ophthalmol 1993;111:503-8.
16. Peto R, Gray R, Collins R, et al. Randomized trial of prophylactic daily aspirin in British male doctors. Br Med J 1988;296:313-6.
17. Chew EY, Williams GA, Burton TC, Barton FB, Remaley NA, Ferris FL 3d. Aspirin effects on the development of cataract in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study Report 16. Arch Ophthalmol 1992;110:339-42.
18. Seddon JM, Christen WG, Manson JE, Buring JE, Sperduto RD, Hennekens CH. Low-dose aspirin and risks of cataract in a randomized trial of US physicians. Arch Ophthalmol 1991;109:252-5.
19. West SK, Valmadrid CT. Epidemiology of risk factors for age-related cataract. Surv Ophthalmol 1995;39:323-34.
20. The Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. New Engl J Med 1989;321:129-35.
21. Cox DR. Regression models and life-tables (with discussion). J Roy Stat Soc (B) 1972;34:187-220.
22. Kleinbaum D, Kupper L, Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods. Belmont, Calif: Lifetime Learning Publications, 1982.
23. Cataract Management Guideline Panel. Management of Cataract in Adults: Clinical Practice Guideline: Quick Reference Guide for Clinicians, Number 4. Rockville, Md: US Dept of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; February 1993. AHCPR publication 93-0543.
24. National Advisory Eye Council. Vision Research: A National Plan 1983-1987, vol 2. Report of the Cataract Panel. NIH Publ No. 83-2473. Bethesda, MD: National Institutes of Health, 1983.
25. Perkins ES. Cataract: Refractive error, diabetes, and morphology. Br J Ophthalmol 1984;68:293-7.
26. Bochow TW, West SK, Azar A, Munoz B, Sommer A, Taylor HR. Ultraviolet light exposure and risk of posterior subcapsular cataracts. Arch Ophthalmol 1989;107:369-72.
27. Adamsons I, Munoz B, Enger C, Taylor HR. Prevalence of lens opacities in surgical and general populations. Arch Ophthalmol 1991;109:993-7.